Effectiveness of remdesivir for hospitalized COVID-19 patients depending on the severity of respiratory status: a multicenter retrospective study in Japan

Effectiveness of remdesivir for hospitalized COVID-19 patients depending on the severity of respiratory status: a multicenter retrospective study in Japan

Abstract Background Remdesivir, an antiviral nucleotide analog prodrug, is approved for clinical use against COVID-19 worldwide. However, its effectiveness varies depending on the respiratory failure status of patients. This study aimed to evaluate the effectiveness of remdesivir treatment based on...

Full description

Saved in:
Bibliographic Details
Main Authors: Hidero Yoshimoto, Kazuma Yamakawa, Yoshihiro Tanaka, Itsuki Osawa, Takashi Tagami, Akira Endo, Ryo Yamamoto, Mineji Hayakawa, Takayuki Ogura, Atsushi Hirayama, Hideo Yasunaga, Akira Takasu, Sang-Woong Lee, J-RECOVER study group
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Infectious Diseases
Subjects:
COVID-19
Remdesivir
Respiratory status
Propensity score
Overlap weighting
Japan
Online Access:https://doi.org/10.1186/s12879-025-11345-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12879-025-11345-z

Similar Items